Maninder Hora compensation by year
NEKTAR THERAPEUTICS Summary Compensation Table · all 3 fiscal years held| Component | FY2016 | FY2017 | FY2018 |
|---|---|---|---|
| Salary | $447,800 | $471,500 | $489,417 |
| Bonus | $0 | $0 | $0 |
| Stock awards | $367,197 | $1,706,998 | $1,350,866 |
| Option awards | $432,450 | $2,118,510 | $1,516,746 |
| Non-equity incentive | $279,875 | $353,625 | $464,900 |
| Pension and deferred compensation | $0 | $0 | $0 |
| All other | $14,454 | $15,394 | $17,513 |
| Total | $1,541,776 | $4,666,027 | $3,839,442 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: NEKTAR THERAPEUTICS DEF 14A filed April 30, 2019, accession 0001193125-19-129488, and prior-year filings. Open the filing on EDGAR.
How this page was built: the NEKTAR THERAPEUTICS filed document, accession 0001193125-19-129488. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2019.
NEKTAR THERAPEUTICS’s named executive officers, FY2018
as the company reported each| Named executive officer | Role | FY2018 total |
|---|---|---|
| Howard Robin | President and Chief Executive Officer | $13,330,667 |
| Jillian Thomsen | Senior Vice President Finance and Chief Accounting Officer | $6,233,595 |
| Gil Labrucherie | Senior Vice President and Chief Financial Officer | $5,733,928 |
| Stephen Doberstein | Chief Research and Development Officer | $4,811,856 |
| Maninder Hora · this page | Senior Vice President Pharmaceutical Development and Chief Technical Operations Officer | $3,839,442 |
The full NEKTAR THERAPEUTICS compensation record
free company briefThis page is one person within NEKTAR THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the NEKTAR THERAPEUTICS proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are NEKTAR THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.